Cargando…
Novel Barbiturate-Nitrate Compounds Inhibit the Upregulation of Matrix Metalloproteinase-9 Gene Expression in Intestinal Inflammation through a cGMP-Mediated Pathway
Matrix metalloproteinase-9 is upregulated in inflammatory bowel disease. Barbiturate nitrate hybrid compounds have been designed to inhibit MMP secretion and enzyme activity. In this study, we investigated the mechanism of action of barbiturate-nitrate hybrid compounds and their component parts usin...
Autores principales: | O’Sullivan, Shane, Wang, Jun, Radomski, Marek W., Gilmer, John F., Medina, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277209/ https://www.ncbi.nlm.nih.gov/pubmed/32466182 http://dx.doi.org/10.3390/biom10050808 |
Ejemplares similares
-
Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update
por: O'Sullivan, Shane, et al.
Publicado: (2015) -
Antiplatelet effects of dietary nitrate in healthy volunteers: Involvement of cGMP and influence of sex()
por: Velmurugan, Shanti, et al.
Publicado: (2013) -
NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009) -
cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015) -
Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)